About Valiant Laboratories Limited
Data last updated: 14 July 2026
Valiant Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 16 August 2021, the company has been in operation for over 5 years.
Registered with ROC Mumbai under CIN L24299MH2021PLC365904. Listed.
Capital: an authorised share capital of ₹60 Cr and a paid-up capital of ₹54.31 Cr. It is led by directors including Santosh Shantilal Vora and Shantilal Shivji Vora.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: 104 Udyog Kshetra Mulundgoregoanlinkroad Mulund West, Mumbai, Maharashtra, India – 400080.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹237.47 Cr, a growth of 78.04% compared to the previous year. The net worth stands at ₹310.89 Cr (up 32.68% YoY). Total assets are valued at ₹463.98 Cr (up 15.75% YoY).
The company has a workforce of approximately 77 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Valiant Laboratories. As per MCA filings, the company has open charges of ₹60.86 Cr and satisfied charges of ₹52 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website valiantlabs.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address104 Udyog Kshetra Mulundgoregoanlinkroad Mulund West, Mumbai, Maharashtra, India – 400080
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Valiant Laboratories Limited
Valiant Laboratories Limited has one previous CIN (Corporate Identification Number): U24299MH2021PLC365904. The current CIN is L24299MH2021PLC365904, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24299MH2021PLC365904 | Current |
| U24299MH2021PLC365904 | Previous |
Associated Brands with Valiant Laboratories Limited
Valiant Laboratories Limited operates one associated brand: Valiant Laboratories. These brands represent Valiant Laboratories Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Valiant Laboratories is engaged in manufacturing active pharmaceutical ingredients. | valiantlabs.in |
Business Activity of Valiant Laboratories Limited
Valiant Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Valiant Laboratories Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Valiant Laboratories Limited
Valiant Laboratories Limited is audited by Raman S. Shah & Co. (ICAI peer reviewed, certificate valid till 2029-02-28) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Raman S. Shah & Co. (ICAI peer reviewed, certificate valid till 2029-02-28) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Valiant Laboratories Limited
Valiant Laboratories Limited is currently managed by 7 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Shantilal Vora | Managing Director | 16 Aug 2021 | 5 Years 0 Months | Current |
| Shantilal Shivji Vora | Director | 16 Aug 2021 | 5 Years 0 Months | Current |
| Paresh Shashikant Shah | Whole-Time Director | 16 Aug 2021 | 5 Years 0 Months | Current |
| Sonal Amit Vira | Director | 16 Feb 2022 | 4 Years 6 Months | Current |
|
Sandeep Gupta
Also directs:
Alchemie Finechem Private Limited
|
Director | 23 Feb 2023 | 3 Years 6 Months | Current |
|
Ashok Lakhamshi Chheda
Also directs:
Stature Realtor Private Limited
|
Director | 12 Nov 2024 | 1 Years 9 Months | Current |
Financials of Valiant Laboratories Limited FY 2026 filings available
Valiant Laboratories Limited reported revenue of ₹237.47 Cr (up 78.04% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Revenue from Operations | ₹237.47 Cr | ₹133.38 Cr | ₹182.06 Cr |
| Other Income | ₹2.32 Cr | ₹5.43 Cr | ₹9.68 Cr |
| Total Income | ₹239.79 Cr | ₹138.82 Cr | ₹191.74 Cr |
| Cost of Materials Consumed | ₹190.8 Cr | ₹112.18 Cr | ₹169.39 Cr |
| Purchases of Stock-in-Trade | ₹9.05 Cr | ₹56.14 Lakh | -₹45.09 Lakh |
| Changes in Inventories | -₹2.68 Cr | ₹3.86 Cr | -₹68.54 Lakh |
| Employee Benefit Expense | ₹7 Cr | ₹4.39 Cr | ₹4.31 Cr |
| Finance Costs | ₹1.9 Cr | ₹17.53 Lakh | ₹7.78 Lakh |
| Depreciation & Amortisation | ₹6.04 Cr | ₹2.09 Cr | ₹1.97 Cr |
| Other Expenses | ₹26.92 Cr | ₹17.07 Cr | ₹17.9 Cr |
| Total Expenses | ₹239.02 Cr | ₹140.33 Cr | ₹192.51 Cr |
| Profit Before Exceptional Items & Tax | ₹76.82 Lakh | -₹1.51 Cr | -₹76.95 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹76.82 Lakh | -₹1.51 Cr | -₹76.95 Lakh |
| Total Tax Expense | ₹4.04 Cr | ₹68.86 Lakh | -₹1.09 Cr |
| Net Profit | -₹3.27 Cr | -₹2.2 Cr | ₹31.96 Lakh |
| attributable to Owners | -₹3.27 Cr | -₹2.2 Cr | ₹31.96 Lakh |
| attributable to NCI | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹42,000 | -₹2.4 Lakh | ₹17.54 Lakh |
| Total Comprehensive Income | -₹3.26 Cr | -₹2.23 Cr | ₹49.5 Lakh |
| EBITDA (computed) | ₹8.71 Cr | ₹75.53 Lakh | ₹1.27 Cr |
| Basic EPS | ₹-0.51 | ₹-0.51 | ₹0.13 |
| Diluted EPS | ₹-0.51 | ₹-0.51 | ₹0.13 |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Total Assets | ₹463.98 Cr | ₹400.86 Cr | ₹342.69 Cr |
| Non-current Assets | ₹235.65 Cr | ₹208.24 Cr | ₹117.14 Cr |
| Current Assets | ₹228.32 Cr | ₹192.62 Cr | ₹225.54 Cr |
| Property, Plant & Equipment | ₹227.01 Cr | ₹48.33 Cr | ₹50.05 Cr |
| Inventories | ₹45.43 Cr | ₹3.99 Cr | ₹10.02 Cr |
| Trade Receivables | ₹93.56 Cr | ₹72.12 Cr | ₹45.73 Cr |
| Cash & Equivalents | ₹3.53 Cr | ₹4.92 Cr | ₹11.72 Cr |
| Equity (Net Worth) | ₹310.89 Cr | ₹234.31 Cr | ₹236.86 Cr |
| Equity Share Capital | ₹54.31 Cr | ₹43.45 Cr | ₹43.45 Cr |
| Borrowings (Non-current) | ₹28.09 Cr | ₹104.35 Cr | ₹74.66 Cr |
| Borrowings (Current) | ₹16.86 Cr | ₹16.86 Cr | ₹1.39 Cr |
| Total Debt (computed) | ₹44.95 Cr | ₹121.2 Cr | ₹76.05 Cr |
| Current Liabilities | ₹119.45 Cr | ₹59.62 Cr | ₹29.08 Cr |
| Total Liabilities | ₹153.09 Cr | ₹166.55 Cr | ₹105.83 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Operating Cash Flow | -₹10.43 Cr | ₹1.31 Cr | ₹1.89 Cr |
| Investing Cash Flow | ₹7.25 Cr | -₹52.77 Cr | -₹143.88 Cr |
| Financing Cash Flow | ₹1.79 Cr | ₹44.65 Cr | ₹152.45 Cr |
| Capital Expenditure | ₹34.2 Cr | ₹113.85 Cr | ₹45.87 Cr |
| Free Cash Flow (computed) | -₹44.63 Cr | -₹112.54 Cr | -₹43.98 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹1.39 Cr | -₹6.8 Cr | ₹10.46 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹91.98 Cr | ₹52.46 Cr | ₹46.2 Cr | ₹46.82 Cr | ₹57.79 Cr | ₹35.23 Cr | ₹21.48 Cr | ₹18.88 Cr | ₹30.59 Cr | ₹40.52 Cr | ₹59.55 Cr |
| Other Income | ₹17.12 Lakh | ₹62.78 Lakh | ₹86.6 Lakh | ₹65.54 Lakh | -₹2.31 Cr | ₹1.58 Cr | ₹3.36 Cr | ₹2.81 Cr | ₹2.5 Cr | ₹1.78 Cr | ₹2.96 Cr |
| Total Income | ₹92.15 Cr | ₹53.09 Cr | ₹47.07 Cr | ₹47.48 Cr | ₹55.47 Cr | ₹36.81 Cr | ₹24.84 Cr | ₹21.7 Cr | ₹33.09 Cr | ₹42.29 Cr | ₹62.51 Cr |
| Cost of Materials Consumed | ₹68.46 Cr | ₹44.5 Cr | ₹42.37 Cr | ₹35.46 Cr | ₹46.78 Cr | ₹29.28 Cr | ₹16.68 Cr | ₹19.68 Cr | ₹30.69 Cr | ₹37.85 Cr | ₹55.39 Cr |
| Purchases of Stock-in-Trade | ₹2.48 Cr | ₹1.87 Cr | ₹14,000 | ₹4.7 Cr | ₹27.88 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹1.2 Cr | -₹1.4 Cr | -₹2.04 Cr | -₹44.09 Lakh | ₹1.16 Cr | -₹55.63 Lakh | ₹3.92 Cr | -₹67.5 Lakh | -₹68.54 Lakh | ₹3.28 Cr | -₹57.23 Lakh |
| Employee Benefit Expense | ₹2.56 Cr | ₹1.95 Cr | ₹1.29 Cr | ₹1.2 Cr | ₹1.13 Cr | ₹1.11 Cr | ₹1.19 Cr | ₹95.95 Lakh | ₹1.26 Cr | ₹1.21 Cr | ₹1.04 Cr |
| Finance Costs | ₹1.01 Cr | ₹68.21 Lakh | ₹13.59 Lakh | ₹7.33 Lakh | ₹5.45 Lakh | ₹6.19 Lakh | ₹61,000 | ₹5.29 Lakh | ₹2.07 Lakh | ₹1.87 Lakh | ₹1.91 Lakh |
| Depreciation & Amortisation | ₹2.93 Cr | ₹2.05 Cr | ₹53.22 Lakh | ₹53.26 Lakh | ₹51.77 Lakh | ₹52.17 Lakh | ₹51.87 Lakh | ₹53.46 Lakh | ₹51.94 Lakh | ₹49.45 Lakh | ₹49 Lakh |
| Other Expenses | ₹12.47 Cr | ₹6.43 Cr | ₹4.51 Cr | ₹3.51 Cr | ₹4.61 Cr | ₹4.78 Cr | ₹6.44 Cr | ₹1.31 Cr | ₹3.85 Cr | ₹4.48 Cr | ₹5.08 Cr |
| Total Expenses | ₹91.11 Cr | ₹56.08 Cr | ₹46.79 Cr | ₹45.03 Cr | ₹54.53 Cr | ₹35.19 Cr | ₹28.74 Cr | ₹21.86 Cr | ₹35.66 Cr | ₹47.33 Cr | ₹61.44 Cr |
| Profit Before Exceptional Items & Tax | ₹1.05 Cr | -₹2.99 Cr | ₹27.65 Lakh | ₹2.45 Cr | ₹93.91 Lakh | ₹1.62 Cr | -₹3.91 Cr | -₹16.2 Lakh | -₹2.57 Cr | -₹5.04 Cr | ₹1.06 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹1.05 Cr | -₹2.99 Cr | ₹27.65 Lakh | ₹2.45 Cr | ₹93.91 Lakh | ₹1.62 Cr | -₹3.91 Cr | -₹16.2 Lakh | -₹2.57 Cr | -₹5.04 Cr | ₹1.06 Cr |
| Total Tax Expense | -₹71.19 Lakh | ₹4.07 Cr | ₹7.64 Lakh | ₹62.78 Lakh | ₹23.55 Lakh | -₹72.67 Lakh | ₹83.25 Lakh | ₹34.74 Lakh | -₹1.33 Cr | -₹1.54 Cr | ₹27.05 Lakh |
| Net Profit | ₹1.76 Cr | -₹7.06 Cr | ₹20.01 Lakh | ₹1.82 Cr | ₹70.36 Lakh | ₹2.35 Cr | -₹4.74 Cr | -₹50.94 Lakh | -₹1.24 Cr | -₹3.5 Cr | ₹79.34 Lakh |
| attributable to Owners | ₹1.76 Cr | -₹7.06 Cr | ₹20.01 Lakh | - | ₹70.36 Lakh | ₹2.35 Cr | -₹4.74 Cr | - | -₹1.24 Cr | -₹3.5 Cr | ₹79.34 Lakh |
| attributable to NCI | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹20,000 | ₹0 | ₹22,000 | ₹0 | -₹2.4 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹17.54 Lakh |
| Total Comprehensive Income | ₹1.76 Cr | -₹7.06 Cr | ₹20.23 Lakh | ₹1.82 Cr | ₹67.96 Lakh | ₹2.35 Cr | -₹4.74 Cr | -₹50.94 Lakh | -₹1.24 Cr | -₹3.5 Cr | ₹96.88 Lakh |
| EBITDA (computed) | ₹4.98 Cr | -₹26.01 Lakh | ₹94.46 Lakh | ₹3.05 Cr | ₹1.51 Cr | ₹2.2 Cr | -₹3.38 Cr | ₹42.55 Lakh | -₹2.03 Cr | -₹4.53 Cr | ₹1.57 Cr |
| Basic EPS | ₹0.32 | ₹-1.30 | ₹0.04 | ₹0.42 | ₹0.16 | ₹0.54 | ₹-1.09 | ₹-0.12 | ₹-0.33 | ₹-0.81 | ₹0.24 |
| Diluted EPS | ₹0.35 | ₹-1.44 | ₹0.04 | ₹0.42 | ₹0.16 | ₹0.54 | ₹-1.09 | ₹-0.12 | ₹-0.33 | ₹-0.81 | ₹0.24 |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Revenue from Operations | ₹217.04 Cr | ₹133.36 Cr | ₹182.05 Cr |
| Other Income | ₹2.89 Cr | ₹5.43 Cr | ₹9.68 Cr |
| Total Income | ₹219.94 Cr | ₹138.79 Cr | ₹191.73 Cr |
| Cost of Materials Consumed | ₹171.53 Cr | ₹112.16 Cr | ₹169.39 Cr |
| Purchases of Stock-in-Trade | ₹15.57 Cr | ₹56.14 Lakh | ₹0 |
| Changes in Inventories | ₹21.38 Lakh | ₹3.86 Cr | -₹1.14 Cr |
| Employee Benefit Expense | ₹5 Cr | ₹4.39 Cr | ₹4.31 Cr |
| Finance Costs | ₹26.11 Lakh | ₹17.53 Lakh | ₹7.78 Lakh |
| Depreciation & Amortisation | ₹2.26 Cr | ₹2.02 Cr | ₹1.95 Cr |
| Other Expenses | ₹17.56 Cr | ₹17.07 Cr | ₹17.9 Cr |
| Total Expenses | ₹212.39 Cr | ₹140.24 Cr | ₹192.49 Cr |
| Profit Before Exceptional Items & Tax | ₹7.55 Cr | -₹1.45 Cr | -₹75.25 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹7.55 Cr | -₹1.45 Cr | -₹75.25 Lakh |
| Total Tax Expense | ₹2 Cr | ₹70.24 Lakh | -₹1.09 Cr |
| Net Profit | ₹5.55 Cr | -₹2.15 Cr | ₹34.03 Lakh |
| Other Comprehensive Income | -₹43,000 | -₹2.26 Lakh | ₹17.54 Lakh |
| Total Comprehensive Income | ₹5.54 Cr | -₹2.17 Cr | ₹51.57 Lakh |
| EBITDA (computed) | ₹10.07 Cr | ₹75.21 Lakh | ₹1.27 Cr |
| Basic EPS | ₹1.02 | ₹-0.50 | ₹0.14 |
| Diluted EPS | ₹1.10 | ₹-0.50 | ₹0.14 |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Total Assets | ₹385.89 Cr | ₹317.28 Cr | ₹324.73 Cr |
| Non-current Assets | ₹196.57 Cr | ₹198.06 Cr | ₹115.46 Cr |
| Current Assets | ₹189.32 Cr | ₹119.22 Cr | ₹209.27 Cr |
| Property, Plant & Equipment | ₹29.59 Cr | ₹29.94 Cr | ₹31.61 Cr |
| Inventories | ₹22.97 Cr | ₹3.96 Cr | ₹10.02 Cr |
| Trade Receivables | ₹83.25 Cr | ₹72.1 Cr | ₹45.72 Cr |
| Cash & Equivalents | ₹3.07 Cr | ₹4.8 Cr | ₹2.23 Cr |
| Equity (Net Worth) | ₹319.76 Cr | ₹234.38 Cr | ₹236.88 Cr |
| Equity Share Capital | ₹54.31 Cr | ₹43.45 Cr | ₹43.45 Cr |
| Borrowings (Non-current) | ₹0 | ₹59.4 Cr | ₹59.4 Cr |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹59.4 Cr | ₹59.4 Cr |
| Current Liabilities | ₹62.68 Cr | ₹20.95 Cr | ₹26.36 Cr |
| Total Liabilities | ₹66.13 Cr | ₹82.9 Cr | ₹87.85 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Operating Cash Flow | -₹13.81 Cr | -₹21.9 Cr | ₹48.78 Cr |
| Investing Cash Flow | -₹8.09 Cr | ₹24.97 Cr | -₹182.73 Cr |
| Financing Cash Flow | ₹20.17 Cr | -₹50.13 Lakh | ₹135.8 Cr |
| Capital Expenditure | ₹1.16 Cr | ₹56.14 Lakh | ₹3.76 Cr |
| Free Cash Flow (computed) | -₹14.97 Cr | -₹22.46 Cr | ₹45.02 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹1.73 Cr | ₹2.57 Cr | ₹1.85 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹65.3 Cr | ₹54.74 Cr | ₹45.99 Cr | ₹51.01 Cr | ₹57.77 Cr | ₹35.23 Cr | ₹21.48 Cr | ₹18.88 Cr | ₹30.58 Cr | ₹40.52 Cr | ₹59.55 Cr |
| Other Income | ₹77.27 Lakh | ₹60.51 Lakh | ₹84.57 Lakh | ₹67.13 Lakh | ₹65.39 Lakh | ₹66.62 Lakh | ₹1.93 Cr | ₹2.17 Cr | ₹2.5 Cr | ₹1.78 Cr | ₹2.96 Cr |
| Total Income | ₹66.08 Cr | ₹55.35 Cr | ₹46.83 Cr | ₹51.68 Cr | ₹58.42 Cr | ₹35.89 Cr | ₹23.41 Cr | ₹21.06 Cr | ₹33.09 Cr | ₹42.29 Cr | ₹62.51 Cr |
| Cost of Materials Consumed | ₹49.5 Cr | ₹40.15 Cr | ₹42.18 Cr | ₹39.69 Cr | ₹46.77 Cr | ₹29.26 Cr | ₹16.68 Cr | ₹19.68 Cr | ₹30.68 Cr | ₹37.85 Cr | ₹55.39 Cr |
| Purchases of Stock-in-Trade | ₹2.48 Cr | ₹8.39 Cr | ₹14,000 | ₹4.7 Cr | ₹27.88 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹2.19 Cr | ₹50.56 Lakh | -₹2.04 Cr | -₹44.09 Lakh | ₹1.16 Cr | -₹54.29 Lakh | ₹3.92 Cr | -₹67.5 Lakh | -₹68.54 Lakh | ₹3.28 Cr | -₹57.24 Lakh |
| Employee Benefit Expense | ₹1.29 Cr | ₹1.24 Cr | ₹1.28 Cr | ₹1.19 Cr | ₹1.13 Cr | ₹1.11 Cr | ₹1.19 Cr | ₹95.95 Lakh | ₹1.26 Cr | ₹1.21 Cr | ₹1.04 Cr |
| Finance Costs | ₹1.72 Lakh | ₹3.47 Lakh | ₹13.59 Lakh | ₹7.33 Lakh | ₹5.45 Lakh | ₹6.19 Lakh | ₹61,000 | ₹5.29 Lakh | ₹2.07 Lakh | ₹1.87 Lakh | ₹1.91 Lakh |
| Depreciation & Amortisation | ₹52.12 Lakh | ₹71.53 Lakh | ₹51.14 Lakh | ₹51.41 Lakh | ₹50.53 Lakh | ₹50.9 Lakh | ₹50.6 Lakh | ₹50.44 Lakh | ₹50.17 Lakh | ₹49.45 Lakh | ₹49 Lakh |
| Other Expenses | ₹5.34 Cr | ₹4.21 Cr | ₹4.5 Cr | ₹3.5 Cr | ₹4.6 Cr | ₹4.78 Cr | ₹6.44 Cr | ₹1.31 Cr | ₹3.85 Cr | ₹4.48 Cr | ₹5.08 Cr |
| Total Expenses | ₹61.34 Cr | ₹55.24 Cr | ₹46.58 Cr | ₹49.23 Cr | ₹54.5 Cr | ₹35.18 Cr | ₹28.73 Cr | ₹21.83 Cr | ₹35.64 Cr | ₹47.33 Cr | ₹61.44 Cr |
| Profit Before Exceptional Items & Tax | ₹4.73 Cr | ₹10.93 Lakh | ₹25.79 Lakh | ₹2.45 Cr | ₹3.92 Cr | ₹71.91 Lakh | -₹5.32 Cr | -₹77.19 Lakh | -₹2.55 Cr | -₹5.04 Cr | ₹1.06 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹4.73 Cr | ₹10.93 Lakh | ₹25.79 Lakh | ₹2.45 Cr | ₹3.92 Cr | ₹71.91 Lakh | -₹5.32 Cr | -₹77.19 Lakh | -₹2.55 Cr | -₹5.04 Cr | ₹1.06 Cr |
| Total Tax Expense | ₹1.2 Cr | ₹7.63 Lakh | ₹9.12 Lakh | ₹63.01 Lakh | ₹68.53 Lakh | -₹88.1 Lakh | ₹66.43 Lakh | ₹23.38 Lakh | -₹1.33 Cr | -₹1.54 Cr | ₹27.05 Lakh |
| Net Profit | ₹3.53 Cr | ₹3.3 Lakh | ₹16.67 Lakh | ₹1.82 Cr | ₹3.24 Cr | ₹1.6 Cr | -₹5.98 Cr | -₹1.01 Cr | -₹1.22 Cr | -₹3.5 Cr | ₹79.34 Lakh |
| Other Comprehensive Income | -₹1.25 Lakh | ₹0 | ₹82,000 | ₹0 | -₹2.27 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹17.54 Lakh |
| Total Comprehensive Income | ₹3.52 Cr | ₹3.3 Lakh | ₹17.49 Lakh | ₹1.82 Cr | ₹3.22 Cr | ₹1.6 Cr | -₹5.98 Cr | -₹1.01 Cr | -₹1.22 Cr | -₹3.5 Cr | ₹96.88 Lakh |
| EBITDA (computed) | ₹5.27 Cr | ₹85.93 Lakh | ₹90.52 Lakh | ₹3.03 Cr | ₹4.48 Cr | ₹1.29 Cr | -₹4.81 Cr | -₹21.46 Lakh | -₹2.03 Cr | -₹4.53 Cr | ₹1.57 Cr |
| Basic EPS | ₹0.65 | ₹0.01 | ₹0.03 | ₹0.42 | ₹0.74 | ₹0.37 | ₹-1.39 | ₹-0.23 | ₹-0.32 | ₹-0.81 | ₹0.24 |
| Diluted EPS | ₹0.70 | ₹0.01 | ₹0.03 | ₹0.42 | ₹0.74 | ₹0.37 | ₹-1.39 | ₹-0.23 | ₹-0.32 | ₹-0.81 | ₹0.24 |
Shareholding Pattern of Valiant Laboratories Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 74.94%, foreign institutional investors hold 0.20%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 24.86% of Valiant Laboratories Limited. The company had 14,657 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Aug 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Promoters | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% |
| Public | 25.06% | 25.06% | 25.06% | 25.06% | 25.06% | 25.06% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 74.94% | 74.94% | 74.94% |
| Public | 25.06% | 25.06% | 25.06% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | - |
Board & Governance of Valiant Laboratories Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Valiant Laboratories Limited has 7 directors - 3 independent and 2 executive. The board is chaired by Mulesh Manilal Savla.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Mulesh Manilal Savla | Non-Executive - Independent Director · Chairperson | 2024-05-14 | 2 |
| Paresh Shashikant Shah | Executive Director | 2021-08-16 | 1 |
| Santosh Shantilal Vora | Executive Director · MD | 2021-08-16 | 2 |
| Shantilal Shivji Vora | Non-Executive - Non Independent Director | 2021-08-16 | 1 |
| Sonal Amit Vira | Non-Executive - Independent Director | 2022-02-16 | 2 |
| Sandeep Gupta | Non-Executive - Non Independent Director | 2023-02-23 | 1 |
| Ashok Lakhamshi Chheda | Non-Executive - Independent Director | 2024-11-12 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Mulesh Manilal Savla (Chairperson), Sonal Amit Vira, Shantilal Shivji Vora, Ashok Lakhamshi Chheda |
| Nomination and remuneration committee | Sonal Amit Vira (Chairperson), Shantilal Shivji Vora, Mulesh Manilal Savla |
| Stakeholders Relationship Committee | Mulesh Manilal Savla (Chairperson), Sonal Amit Vira, Santosh Shantilal Vora |
| Risk Management Committee | Santosh Shantilal Vora (Chairperson), Sonal Amit Vira, Mulesh Manilal Savla, Paresh Shashikant Shah |
| Corporate Social Responsibility Committee | Mulesh Manilal Savla (Chairperson), Paresh Shashikant Shah, Shantilal Shivji Vora |
| Restructuring Committee | Mulesh Manilal Savla (Chairperson), Ashok Lakhamshi Chheda, Santosh Shantilal Vora |
Group Structure of Valiant Laboratories Limited
Valiant Laboratories Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Valiant Laboratories Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Valiant Advanced Sciences Private Limited | U24290MH2022PTC386388 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Valiant Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 May 2025 | The Hongkong and Shanghai Banking Corporation Limited | ₹1 Cr | Open |
| 08 Jun 2024 | The Hongkong and Shanghai Banking Corporation Limited | ₹2.86 Cr | Open |
| 28 Feb 2024 | The Hongkong and Shanghai Banking Corporation Limited | ₹5 Cr | Open |
| 23 Sep 2022 | Others | ₹52 Cr | Open |
| 14 Oct 2022 | Others | ₹52 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Valiant Laboratories Limited
Valiant Laboratories Limited has a workforce of 77 employees as of Apr 08, 2025.
Employee and EPFO history for Valiant Laboratories Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Valiant Laboratories Limited
GST registrations and filing compliance for Valiant Laboratories Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Valiant Laboratories Limited
Credit ratings, litigation, and regulatory alerts for Valiant Laboratories Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Valiant Laboratories Limited
MSME payment history for Valiant Laboratories Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Valiant Laboratories Limited
Corporate group structure for Valiant Laboratories Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Valiant Laboratories Limited
MCA filings and documents for Valiant Laboratories Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Valiant Laboratories Limited
Recent News on Valiant Laboratories Limited
Frequently Asked Questions about Valiant Laboratories Limited
Valiant Laboratories Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 16 August 2021 (5+ years old) and is registered under CIN L24299MH2021PLC365904. The company has 77 employees.
Valiant Laboratories Limited reported revenue of ₹237.47 Cr for FY 2026 (up 78.04% YoY) based on consolidated NSE filings.
The current directors of Valiant Laboratories Limited are:
- Santosh Shantilal Vora - Managing Director
- Shantilal Shivji Vora - Director
- Paresh Shashikant Shah - Whole-Time Director
- Sonal Amit Vira - Director
- Sandeep Gupta - Director
- Ashok Lakhamshi Chheda - Director
- Mulesh Manilal Savla - Director
The primary industry of Valiant Laboratories Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes, Valiant Laboratories Limited is a listed company.
Valiant Laboratories Limited can be reached at the registered office: 104 Udyog Kshetra Mulundgoregoanlinkroad Mulund West, Mumbai, Maharashtra, India – 400080, or through the website valiantlabs.in.